Clarke Barlow

Clarke Barlow

Fundador en AMG ACQUISITION CORP. .

Fortuna: 18 997 $ al 31/10/2023

43 años
Health Technology
Finance
Consumer Services

Perfil

Clarke Barlow is the founder of AMG Acquisition Corp., which was founded in 2021.
He is currently the Director at Neuroscientific Biopharmaceuticals Ltd.
since 2023, Non-Executive Director at Tryptamine Therapeutics Ltd.
since 2024, and a Member at the Australian Institute of Co. Directors.
He previously served as a Non-Executive Director at Exopharm Ltd.
Mr. Barlow completed his undergraduate degree at The University of Western Australia.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
27/04/2023 533 340 ( 6.84% ) 15 467 $ 30/04/2024
0.12%
01/05/2024 508 000 ( 0.12% ) 3 531 $ 31/10/2023

Cargos activos de Clarke Barlow

EmpresasCargoInicio
AMG ACQUISITION CORP. Fundador 01/06/2021
NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED Director/Miembro de la Junta 17/11/2023
Corporate Officer/Principal -
Todos los cargos activos de Clarke Barlow

Antiguos cargos conocidos de Clarke Barlow.

EmpresasCargoFin
EXOPHARM Director/Miembro de la Junta -
Ver el detalle de la experiencia de Clarke Barlow.

Formación de Clarke Barlow.

The University of Western Australia Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Clarke Barlow.

Relaciones

100 +

Relaciones de 1er grado

5

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
AMG ACQUISITION CORP.

Finance

NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED

Health Technology

Empresas privadas2

Commercial Services

Health Technology

Ver las conexiones de la empresa